SCNN1B and Liddle syndrome: Based on this presentation, genetic testing for the locally prevalent c.1815G>A (p.R563Q)1 Liddle’s syndrome-associated genetic variant in the SCNN1B gene was requested, and his treatment was intensified to include doxazosin as no amiloridecontaining medications were available at the time.